The Interventional Radiology Imaging Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments- By Product (MRI System, Ultrasound Imaging System, CT Scanner, Angiography System, Fluoroscopy System, Biopsy System, Others), By Procedure ( Angiography, Angioplasty, Embolization, Biopsy, Vertebroplasty, Thrombolysis, Nephrostomy Placement, Others), By Application (Oncology, Cardiology, Urology & Nephrology, Gastroenterology, Others).
Interventional radiology (IR) imaging plays a pivotal role in guiding minimally invasive procedures to diagnose and treat a wide range of medical conditions, including vascular diseases, cancer, and chronic pain. In 2024, IR imaging technologies continue to advance, enabling high-resolution, real-time visualization of anatomical structures and pathology during image-guided interventions. Fluoroscopy, digital subtraction angiography (DSA), computed tomography (CT), and magnetic resonance imaging (MRI) are among the imaging modalities utilized by interventional radiologists to guide catheter-based procedures, biopsy techniques, and ablative therapies with precision and accuracy. Moreover, innovations such as cone-beam CT (CBCT), three-dimensional (3D) rotational angiography, and fusion imaging techniques enhance procedural planning, navigation, and intraprocedural imaging, improving patient outcomes and procedural efficiency. As the scope of interventional radiology expands to include complex interventions and personalized treatment approaches, IR imaging remains indispensable in delivering minimally invasive therapies while minimizing patient discomfort, recovery time, and treatment-related complications.
A prominent trend in the interventional radiology imaging market is the continuous advancements in imaging technology and techniques. With ongoing innovation in modalities such as fluoroscopy, computed tomography (CT), magnetic resonance imaging (MRI), and ultrasound, interventional radiologists have access to increasingly sophisticated tools for visualization and guidance during minimally invasive procedures. These advancements enable higher resolution imaging, improved soft tissue contrast, faster acquisition times, and enhanced real-time visualization of anatomical structures and pathological conditions, facilitating precise and effective interventional procedures. Furthermore, developments in image fusion, 3D reconstruction, and augmented reality further enhance procedural planning and execution, driving a shift towards more personalized and minimally invasive interventions in interventional radiology.
A key driver propelling the interventional radiology imaging market is the growing demand for minimally invasive treatments across a wide range of medical specialties. Patients increasingly prefer minimally invasive procedures over traditional surgical interventions due to benefits such as reduced trauma, shorter recovery times, and lower risk of complications. Interventional radiology techniques, which utilize imaging guidance to perform minimally invasive procedures such as angioplasty, embolization, biopsy, and ablation, offer effective treatment options for various conditions including cardiovascular diseases, cancer, and musculoskeletal disorders. The rising prevalence of chronic diseases, coupled with the aging population and advancements in medical technology, fuels the demand for interventional radiology imaging solutions that enable clinicians to perform precise and safe interventions while improving patient outcomes and quality of life.
An opportunity for growth in the interventional radiology imaging market lies in the expansion of image-guided therapies beyond traditional applications into new medical specialties and clinical indications. While interventional radiology has historically been associated with vascular and oncological interventions, there is potential to leverage imaging-guided techniques for a broader range of conditions such as neurological disorders, urological conditions, and gastrointestinal diseases. By expanding the scope of image-guided therapies and collaborating with multidisciplinary teams across different medical specialties, interventional radiologists can address unmet clinical needs, improve patient access to minimally invasive treatments, and drive innovation in interventional radiology imaging technologies. Furthermore, partnerships with industry stakeholders, research institutions, and regulatory agencies can accelerate the development and commercialization of novel image-guided therapies, positioning interventional radiology as a key player in the future of precision medicine and personalized healthcare.
The MRI Systems segment within the Interventional Radiology Imaging Market is experiencing the most rapid growth, particularly in oncology imaging, and several factors contribute to this trend. Firstly, magnetic resonance imaging (MRI) offers unique advantages for oncology imaging, including excellent soft tissue contrast, multi-parametric imaging capabilities, and lack of ionizing radiation, making it well-suited for detecting and characterizing tumors, assessing treatment response, and guiding interventional procedures. MRI plays a crucial role in oncology management by providing detailed anatomical and functional information, facilitating accurate tumor staging, treatment planning, and monitoring of therapeutic efficacy. Additionally, advancements in MRI technology, such as higher magnetic field strengths, faster imaging sequences, and improved image resolution, have enhanced the diagnostic accuracy and clinical utility of MRI in oncology. Moreover, the increasing adoption of advanced MRI techniques, including diffusion-weighted imaging (DWI), perfusion imaging, spectroscopy, and functional MRI (fMRI), allows for comprehensive tumor assessment and personalized treatment strategies tailored to individual patient needs. Furthermore, the expanding applications of MRI in oncology beyond traditional anatomical imaging, such as functional and molecular imaging for tumor characterization and assessment of treatment response, have contributed to its growing utilization in cancer care. Overall, the MRI Systems segment in oncology imaging is experiencing rapid growth due to its superior imaging capabilities, technological advancements, expanding clinical applications, and increasing demand for personalized oncology care.
The market research study provides in-depth insights into leading companies including the SWOT analyses, product profile, financial details, and recent developments acrossCanon Medical Systems Corp, Carestream Health Inc, Esaote S.p.A., FUJIFILM Corp, GE Healthcare, Hitachi Healthcare Americas, Hologic Inc, Koninklijke Philips N.V., Samsung Medison Co. Ltd, Shimadzu Corp, Siemens Healthcare GmbH
By Product
MRI System
Ultrasound Imaging System
CT Scanner
Angiography System
Fluoroscopy System
Biopsy System
Others
By Procedure
Angiography
Angioplasty
Embolization
Biopsy
Vertebroplasty
Thrombolysis
Nephrostomy Placement
Others
By Application
Oncology
Cardiology
Urology & Nephrology
Gastroenterology
Others
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
Canon Medical Systems Corp
Carestream Health Inc
Esaote S.p.A.
FUJIFILM Corp
GE Healthcare
Hitachi Healthcare Americas
Hologic Inc
Koninklijke Philips N.V.
Samsung Medison Co. Ltd
Shimadzu Corp
Siemens Healthcare GmbH
• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Interventional Radiology Imaging Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Interventional Radiology Imaging Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.
TABLE OF CONTENTS
1 Introduction to 2024 Interventional Radiology Imaging Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Covered
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain
2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations
3 Executive Summary
3.1 Global Interventional Radiology Imaging Market Size Outlook, $ Million, 2021 to 2030
3.2 Interventional Radiology Imaging Market Outlook by Type, $ Million, 2021 to 2030
3.3 Interventional Radiology Imaging Market Outlook by Product, $ Million, 2021 to 2030
3.4 Interventional Radiology Imaging Market Outlook by Application, $ Million, 2021 to 2030
3.5 Interventional Radiology Imaging Market Outlook by Key Countries, $ Million, 2021 to 2030
4 Market Dynamics
4.1 Key Driving Forces of Interventional Radiology Imaging Industry
4.2 Key Market Trends in Interventional Radiology Imaging Industry
4.3 Potential Opportunities in Interventional Radiology Imaging Industry
4.4 Key Challenges in Interventional Radiology Imaging Industry
5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Interventional Radiology Imaging Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook
6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts
7 Global Interventional Radiology Imaging Market Outlook by Segments
7.1 Interventional Radiology Imaging Market Outlook by Segments, $ Million, 2021- 2030
By Product
MRI System
Ultrasound Imaging System
CT Scanner
Angiography System
Fluoroscopy System
Biopsy System
Others
By Procedure
Angiography
Angioplasty
Embolization
Biopsy
Vertebroplasty
Thrombolysis
Nephrostomy Placement
Others
By Application
Oncology
Cardiology
Urology & Nephrology
Gastroenterology
Others
8 North America Interventional Radiology Imaging Market Analysis and Outlook To 2030
8.1 Introduction to North America Interventional Radiology Imaging Markets in 2024
8.2 North America Interventional Radiology Imaging Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Interventional Radiology Imaging Market size Outlook by Segments, 2021-2030
By Product
MRI System
Ultrasound Imaging System
CT Scanner
Angiography System
Fluoroscopy System
Biopsy System
Others
By Procedure
Angiography
Angioplasty
Embolization
Biopsy
Vertebroplasty
Thrombolysis
Nephrostomy Placement
Others
By Application
Oncology
Cardiology
Urology & Nephrology
Gastroenterology
Others
9 Europe Interventional Radiology Imaging Market Analysis and Outlook To 2030
9.1 Introduction to Europe Interventional Radiology Imaging Markets in 2024
9.2 Europe Interventional Radiology Imaging Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Interventional Radiology Imaging Market Size Outlook by Segments, 2021-2030
By Product
MRI System
Ultrasound Imaging System
CT Scanner
Angiography System
Fluoroscopy System
Biopsy System
Others
By Procedure
Angiography
Angioplasty
Embolization
Biopsy
Vertebroplasty
Thrombolysis
Nephrostomy Placement
Others
By Application
Oncology
Cardiology
Urology & Nephrology
Gastroenterology
Others
10 Asia Pacific Interventional Radiology Imaging Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific Interventional Radiology Imaging Markets in 2024
10.2 Asia Pacific Interventional Radiology Imaging Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Interventional Radiology Imaging Market size Outlook by Segments, 2021-2030
By Product
MRI System
Ultrasound Imaging System
CT Scanner
Angiography System
Fluoroscopy System
Biopsy System
Others
By Procedure
Angiography
Angioplasty
Embolization
Biopsy
Vertebroplasty
Thrombolysis
Nephrostomy Placement
Others
By Application
Oncology
Cardiology
Urology & Nephrology
Gastroenterology
Others
11 South America Interventional Radiology Imaging Market Analysis and Outlook To 2030
11.1 Introduction to South America Interventional Radiology Imaging Markets in 2024
11.2 South America Interventional Radiology Imaging Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Interventional Radiology Imaging Market size Outlook by Segments, 2021-2030
By Product
MRI System
Ultrasound Imaging System
CT Scanner
Angiography System
Fluoroscopy System
Biopsy System
Others
By Procedure
Angiography
Angioplasty
Embolization
Biopsy
Vertebroplasty
Thrombolysis
Nephrostomy Placement
Others
By Application
Oncology
Cardiology
Urology & Nephrology
Gastroenterology
Others
12 Middle East and Africa Interventional Radiology Imaging Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa Interventional Radiology Imaging Markets in 2024
12.2 Middle East and Africa Interventional Radiology Imaging Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Interventional Radiology Imaging Market size Outlook by Segments, 2021-2030
By Product
MRI System
Ultrasound Imaging System
CT Scanner
Angiography System
Fluoroscopy System
Biopsy System
Others
By Procedure
Angiography
Angioplasty
Embolization
Biopsy
Vertebroplasty
Thrombolysis
Nephrostomy Placement
Others
By Application
Oncology
Cardiology
Urology & Nephrology
Gastroenterology
Others
13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Canon Medical Systems Corp
Carestream Health Inc
Esaote S.p.A.
FUJIFILM Corp
GE Healthcare
Hitachi Healthcare Americas
Hologic Inc
Koninklijke Philips N.V.
Samsung Medison Co. Ltd
Shimadzu Corp
Siemens Healthcare GmbH
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise
By Product
MRI System
Ultrasound Imaging System
CT Scanner
Angiography System
Fluoroscopy System
Biopsy System
Others
By Procedure
Angiography
Angioplasty
Embolization
Biopsy
Vertebroplasty
Thrombolysis
Nephrostomy Placement
Others
By Application
Oncology
Cardiology
Urology & Nephrology
Gastroenterology
Others
Countries Analyzed
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
The global Interventional Radiology Imaging Market is one of the lucrative growth markets, poised to register a 6.1% growth (CAGR) between 2024 and 2030.
Emerging Markets across Asia Pacific, Europe, and Americas present robust growth prospects.
Canon Medical Systems Corp, Carestream Health Inc, Esaote S.p.A., FUJIFILM Corp, GE Healthcare, Hitachi Healthcare Americas, Hologic Inc, Koninklijke Philips N.V., Samsung Medison Co. Ltd, Shimadzu Corp, Siemens Healthcare GmbH
Base Year- 2023; Estimated Year- 2024; Historic Period- 2018-2023; Forecast period- 2024 to 2030; Currency: USD; Volume